Esha Leyden is a Peer Harm Reduction Worker at QuIHN (Queensland Injectors Health Network.) And also, a AIVL (Australian Injecting and Illicit Drug Users League) board member. Esha has worked in the drug sector for the past 9 years and has been a member of the drug-using community for the past 36 years. Esha has lived experience in a hepatitis C and treatment, Justice and custodial setting, and injecting drugs use, which allows her to understand the challenges and stigma/ Discrimination faced by the community and their ongoing needs. Esha has been a part of many forums, symposiums and committees and presenting at various state and national conferences on my lived experience and advocated for people who inject drugs. Esha was one of the main people and the Queensland Rep for the ‘IT’S YOUR RIGHT’ National peer health Campaign for Hepatitis C.

Grace is a Clinical Nurse with West Moreton Health Alcohol and Other Drug Services (AODS). They lead the Hepatitis C clinic and rural outreach program, expanding testing into community and inpatient mental health units and delivering the Hepatitis C Roadshow community pop-up clinics across rural areas.

Dr Keri Alexander is an addiction medicine specialist with over 15 years experience in the field. She is passionate about vulnerable patient populations having improved access to quality healthcare. Her roles include working within the Hamilton Centre, collaborating to improve integrated delivery of care for mental health consumers.

Lisa is a Clinical Nurse with West Moreton Health Alcohol and Other Drug Services (AODS). They lead the Hepatitis C clinic and rural outreach program, expanding testing into community and inpatient mental health units and delivering the Hepatitis C Roadshow community pop-up clinics across rural areas.

I am a Nurse Practitioner in Adelaide, specialising in AOD sector. I enjoy the rewards and challenges in providing hepatitis C care and treatment. I am the clinical lead for my organisation's participation in the hepatitis C POCT main study, a role I value and enjoy.

Nigel is the state-wide coordinator of the NSW HIV and Hepatitis C Dried Blood Spot (DBS) Project. He has coordinated this observational study for approximately 7 years and is in the process of assisting the transition of DBS testing for hepatitis C from research in routine clinical care across NSW.

Dr Ciaran Kelly is a Public Health Registrar at Boorloo (Perth) Public Health Unit. He has a keen interest in communicable disease control, chronic disease prevention and systems improvement.

John is a Policy Analyst at Hepatitis Australia, having worked in the hepatitis community since 2012. Before that he had government roles in Aboriginal and Torres Strait Islander health policy and alcohol and other drug policy.

I am a clinical professional based in Sydney, Australia, specializing in viral hepatitis, advanced liver disease and liver cancer research. I am associated with the Western Sydney Local Health District (WSLHD), where she has worked as an Acting Clinical Nurse Consultant.

Grace Hogan brings extensive experience working in hepatitis communications and partnerships, including delivery of major national initiatives such as World Hepatitis Day in Australia.

Prof Jess Howell is a gastroenterologist, NHMRC principal research fellow and Head of the Hepatitis B and Liver Cancer working group at Burnet Institute and honorary Professorial Fellow in the Department of Medicine, University of Melbourne.

Tracey has held many roles in the viral Hepatitis sector including founding President of the Australasian Hepatology Association; Clinical Nursing Educator for ASHM; member of the Hep NSW Board of Governance. Tracey was the first Hepatology Nurse Practitioner in NSW, endorsed in 2007 and currently works for Justice Health NSW.

Nurse Practitioner in Regional Victoria with special interest in Blood Bourne Viruses , including the viral hepatitis's. Working in Infectious Diseases at Bendigo Health for previous 12 years, with a background in sexual health and a passion for rural and remote health provison. HBV & HIV prescriber and MATOD precriber.

Ali Lori is the Clinic Coordinator/HepLink Project Officer at HepatitisWA, bringing over a decade of experience across community and clinical services. Ali has facilitated the prison-based HIP HOP program, coordinated NSP and volunteers, delivered Hepatitis B education for CaLD communities and for six years has specialised in clinical service delivery.

Hendry Luis, MD, is a physician and researcher at Bali Peduli Foundation, focusing on HIV, sexual health, and community health initiatives. An alumnus of the CHART Program at the Kirby Institute, his work centers on implementation research and social determinants to strengthen programs and expand equitable access in Indonesia.

Hepatology Clinical Nurse Consultant at Liverpool Hospital which is a tertiary referral hospital in Sydney, Australia. Working in Liver disease since 2018.

Jess is a Registered Nurse at The Deen Clinic. Her nursing experience includes general practice, aged care and school nursing. Jess has excellent knowledge of viral hepatitis, chronic disease management, immunisations and wound care and has been actively involved in educational activities and events focusing on viral hepatitis.

I am a postdoctoral scientist, with an interest in viral whole genome sequencing and metagenomic approaches. I completed my PhD from UWA in 2021 and have worked at the Kirby since 2025 on the H2Seq initiative, working on optimising HCV whole genome sequencing methods for wider implementation

Tracy is a medical doctor currently working for the Communicable Disease Control Branch in SA Health. This research forms part of her training to become a public health specialist.

Minani Eddy Michel has been with BAPUD since 2017, holding roles from community M&E officer to program manager. With a degree in social sciences, he advocates for harm reduction in Burundi, promoting opioid substitution therapy, HIV treatment access, and integrating viral hepatitis care into BAPUD’s programs

Georgia is a Hepatology Clinical Nurse Consultant on the 'C No More' mobile hepatitis C van; a nurse and peer partnership targeting community corrections populations across Melbourne. She has a background in homeless health, HIV and emergency nursing and has worked in remote and regional areas across Australia.

Alain is a health promotion officer at LiverWELL. who leads LiverWELL's Awareness Raising and Prevention portfolio and drives LiverWELLs approaches to youth and CALD community engagement. His interests include equitable access and health promotion for vulnerable and disadvantaged communities. Alain is also on the board of NEWGENs.

Joseph joined Hepatitis ACT in 2025 with over a decade of nursing experience in haematology/oncology. He has worked with Australian Red Cross Lifeblood and NHSBT in London, supporting transfusion care. After relocating to Canberra in 2023, Joe developed a strong interest in community health and supporting people affected by hepatitis.

Lana has worked in the BBV space for 20 years across a range of organisations, including ASHM, Hepatitis Queensland and NTAHC. She is passionate about finding creative solutions to barriers that impact those most in need of education and advovacy around HBV and HCV particularly in the corrections space.

I am a Consultant Venereologist and a public health specialist and serves as the Monitoring & Evaluation specialist for the GFATM Local funding agency - Deloitte Sri Lanka. I also serve as the chairperson of the AIDS Foundation Sri Lanka the only non profit organization to support people with HIV.

I am a peer. I draw on my education and work experience in health promotion, harm reduction, community involvement and time working in the prisons, to deliver the Hepatitis C custodial arm of Its Your Right Campaign for AIVL in collaboration with Burnet, EC Australia and the AIVL Member organisations

Ashma Shrestha is the Lead Policy Analyst at Hepatitis Australia. She brings extensive experience in policy advocacy, strategic communications, and social and behaviour change programming across global health and within Australia. Before joining Hepatitis Australia, Ashma worked with UN Women and UNICEF in South Asia, the Middle East, and Africa.

Emily Skillin is a Program Manager at Hepatitis Australia, supporting delivery of the HepLink program in partnership with the eight state/territory community hepatitis organisations. She brings broad experience in health policy and program development, with a background in pharmaceutical policy, economic evaluation, medical research strategy, grant funding, and clinical trials.

As Austin Health's Hepatitis C Outreach Nurse with additional clinical responsibilities in the fatty liver clinic. She has previously worked as the Advanced Endoscopy Nurse Coordinator at Austin Health. She is committed to improving health outcomes for underserved populations through tailored education and innovative care pathways.

Heather Valerio is a senior research associate in the Viral Hepatitis Clinical Research Program at The Kirby Institute.

Sofia Villar is a pharmacist with experience in community pharmacy and pharmaceutical marketing. At HepatitisWA, she delivers BBV workforce training across Western Australia and leads organisational marketing. Her work focuses on preventative health and strengthening workforce capacity to support marginalised communities.

Caitlin Wilshin is a Senior Project Officer working at the Western Australian Department of Health.

I am a Clinical Nurse Specialist in Research and Quality at Sydney Sexual Health Centre. I lead a nurse-led FibroScan clinic providing culturally responsive chronic hepatitis B care, support quality improvement initiatives, and work across clinical, research, and digital systems to improve outcomes for priority populations.

Shreyasi Athalye is a PhD scholar and biomedical researcher specialising in hepatitis B virus infection, host genetics, and molecular epidemiology. Her work integrates genomic, immunological, and public health approaches to understand HBV transmission and disease outcomes. She is actively involved in translational research to advance evidence-based strategies for viral hepatitis.

Anindita Banerjee currently works at ICMR NIRBID as a physician scientist in areas are public health infectious diseases, HIV, viral Hepatitis, Immunology. She worked in the Department of Biochemistry, Institute of Post-Graduate Medical Education and Research. Anindita does research in Neuroscience, Diabetes , autoimmune diseases, molecular epidemiology and biomarkers

Edward Jeffrey Boima is Executive Director of the Sierra Liver Foundation (SiLiFo), health advocate, agricultural developer, human rights advocate, and community leader in Sierra Leone. He leads disease awareness initiatives, promotes health equity, supports vulnerable populations, champions agricultural development through BaDDeFCo, and advocates for African unity, mobility, and empowerment.

A bioinformatician and human geneticist specializing in viral genomics, phylogenetics, and evolutionary dynamics. A postdoctoral fellow and also Head of Bioinformatics at the Botswana Harvard Health Institute, he develops computational tools for HBV and HIV research, focusing on viral evolution, transmission dynamics, mixed infections, immune escape, and genomic surveillance.

Jonathan is based at the Collaboration for Evidence, Research and Impact in Public Health (CERIPH) at Curtin University, a member of the management team for the Sexual Health and Blood-borne Virus Applied Research and Evaluation Network (SiREN) and an IUHPE Registered Health Promotion Practitioner.

Anngie Everitt is a Nurse Practitioner based in Darwin, Northern Territory, working across hepatitis and sexual health. Her work focuses on nurse-led and peer-supported models of care that improve engagement, continuity and equitable access for marginalised populations living with viral hepatitis.

Dr Storm Holwill is a Public Health Physician within the Victorian Public Health Network and Senior Clinical Advisor at the WHOCCVH at the Doherty Institute.

Vivek Kumar is a PhD scholar at ICMR–National Institute of Immunohaematology (NIIH), Mumbai, India. His research focuses on chronic hepatitis C, immune restoration, mitochondrial dysfunction, and precision medicine using genomic, immunological, and molecular approaches to improve patient outcomes following antiviral therapy.

PhD researcher at Jawaharlal Nehru Tropical Botanic Garden and Research Institute specializing in plant-based drug discovery and bioinformatics. Research focuses on computational approaches for antiviral drug discovery, including molecular docking, phytochemical screening, ADMET prediction, and molecular dynamics simulation, with particular interest in Hepatitis B virus therapeutics.

Anna Mathews is a first year PhD student investigating immune dysregulation in chronic Hepatitis B, with a focus on natural killer cell phenotypes and receptor expression. Her research also explores phytocompounds with anti-HBV and immunomodulatory properties as potential candidates for adjunct therapy.

Dr Van Thi Thuy Nguyen, infectious disease specialist with over 30 years’ experience, holds a PhD in Public Health from UNSW. At WHO Viet Nam, she advises on HIV, viral hepatitis, and STIs, pioneering innovative approaches to expand testing, treatment access, and national strategies for communicable disease control.

Dr Jo Peel is a dual-trained Infectious Diseases and Sexual Health physician with clinical and research interests in HIV, viral hepatitis, and healthcare equity. She is particularly passionate about improving access to care for marginalised populations and reducing disparities in infectious diseases outcomes.

Hannah Reedy is a Project Manager at Menzies School of Health Research, working across hepatitis B and syphilis programs in the NT. Her work focuses on culturally responsive models of care, workforce education, and improving engagement in care for First Nations communities through outreach, quality improvement, and community-centred approaches.